Please login to your online account to display your discounted pricing

CD199 (CCR9) Mouse anti-Mouse, FITC, Clone: eBioCW-1.2 (CW-1.2), eBioscience™

Mouse Monoclonal Antibody

$129.05 - $506.05

Specifications

Antigen CD199 (CCR9)
Clone eBioCW-1.2 (CW-1.2)
Host Species Mouse
Species Reactivity Mouse
Applications Flow Cytometry
View More Specs

 Disclaimers

For Research Use Only.

Products
Catalog Number Mfr. No. Quantity Price Quantity    

509784

 
affymetrix
11199180
25μg Each for $129.05

509785

 
affymetrix
11-1991-82
100μg Each for $303.05

509786

 
affymetrix
11-1991-85
500μg Each for $506.05
Description & Specifications

Specifications

Antigen CD199 (CCR9)
Clone eBioCW-1.2 (CW-1.2)
Host Species Mouse
Species Reactivity Mouse
Applications Flow Cytometry
Regulatory Status RUO
Conjugate FITC
Format Conjugated
Storage Requirements Store at 2-8°C. Do not freeze. Light-sensitive material.
Primary or Secondary Primary
Monoclonal or Polyclonal Monoclonal
Formulation aqueous buffer, 0.09% sodium azide, may contain carrier protein/stabilizer
Concentration 0.5mg/mL

The eBioCW-1.2 monoclonal antibody reacts with mouse CCR9 (CD199), which is the receptor for thymus-expressed chemokine (TECK). CCR9 is a member of the G protein coupled receptor (GPCR) supergene family, and is involved in trafficking of T cell progenitors within the thymus. CCR9 expression during thymocyte development commences at the double-negative (DN) 3 stage (CD4-CD8-CD25+CD44-), peaks in the double-positive (DP) stage (CD4+CD8+CD25-CD44-), and is down-regulated in commited CD4+ or CD8+ single-positive (SP) thymoyctes. CCR9-deficient mice show a mild impairment in thymoycte development. In the periphery, CCR9 is thought to be expressed on naïve CD8+ T cells, but not on naïve CD4+ T cells.